We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+1,389.53%
AUM
$591B
AUM Growth
-$94.6B
Cap. Flow
+$3.09B
Cap. Flow %
0.52%
Top 10 Hldgs %
20.46%
Holding
2,656
New
75
Increased
1,551
Reduced
819
Closed
97

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$2.72B
2
BKNG icon
Booking.com
BKNG
+$2.61B
3
RHT
Red Hat Inc
RHT
+$1.62B
4
JPM icon
JPMorgan Chase
JPM
+$1.43B
5
STT icon
State Street
STT
+$1.29B

Sector Composition

Rank Sector Weight
1 Healthcare 18.85%
2 Technology 18.49%
3 Financials 14.29%
4 Consumer Discretionary 14.06%
5 Communication Services 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TECX
1251
Tectonic Therapeutic
TECX
$662M
$13.4M ﹤0.01%
67,155
+320
+0.5% +$97.5K
ZION icon
1252
Zions Bancorporation
ZION
$10.6B
$13.4M ﹤0.01%
327,990
+10,500
+3% +$489K
MYOV
1253
DELISTED
Myovant Sciences Ltd.
MYOV
$13.3M ﹤0.01%
810,848
+1,468
+0.2% +$28.9K
AERI
1254
DELISTED
Aerie Pharmaceuticals
AERI
$13.3M ﹤0.01%
367,140
+820
+0.2% +$38.5K
SFLY
1255
DELISTED
Shutterfly, Inc.
SFLY
$13.2M ﹤0.01%
328,660
-3,292
-1% -$173K
NTRA icon
1256
Natera
NTRA
$44.5B
$13.2M ﹤0.01%
942,505
-112,957
-11% -$2.06M
LBRDA icon
1257
Liberty Broadband Class A
LBRDA
$5.25B
$13M ﹤0.01%
181,710
+25
+0% +$2.01K
CRNX icon
1258
Crinetics Pharmaceuticals
CRNX
$8.98B
$13M ﹤0.01%
433,996
+91
+0% +$2.56K
WU icon
1259
Western Union
WU
$2.3B
$13M ﹤0.01%
760,442
+11,600
+2% +$211K
BWA icon
1260
BorgWarner
BWA
$14B
$12.9M ﹤0.01%
423,272
+29,195
+7% +$979K
FLIR
1261
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$12.9M ﹤0.01%
295,942
+1,568
+0.5% +$77.1K
PHM icon
1262
Pultegroup
PHM
$24.7B
$12.8M ﹤0.01%
493,970
-1,034
-0.2% -$25.6K
AIV
1263
Aimco
AIV
$381M
$12.8M ﹤0.01%
2,184,142
+301,773
+16% +$1.79M
HWM icon
1264
Howmet Aerospace
HWM
$114B
$12.7M ﹤0.01%
981,822
+60,636
+7% +$947K
IVZ icon
1265
Invesco
IVZ
$14.3B
$12.7M ﹤0.01%
756,767
-99,333
-12% -$1.99M
BFH icon
1266
Bread Financial
BFH
$4.58B
$12.6M ﹤0.01%
105,554
+4,761
+5% +$747K
INDA icon
1267
iShares MSCI India ETF
INDA
$6.56B
$12.6M ﹤0.01%
378,700
-495,159
-57% -$15.6M
TUES
1268
DELISTED
Tuesday Morning Corp
TUES
$12.6M ﹤0.01%
7,403,375
+515,520
+7% +$1.39M
LKQ icon
1269
LKQ Corp
LKQ
$6.45B
$12.6M ﹤0.01%
530,008
+13,063
+3% +$355K
LGF.B
1270
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$12.5M ﹤0.01%
842,965
-27,575
-3% -$498K
IPGP icon
1271
IPG Photonics
IPGP
$3.64B
$12.5M ﹤0.01%
110,112
+2,310
+2% +$307K
WHR icon
1272
Whirlpool
WHR
$2.73B
$12.4M ﹤0.01%
116,031
-1,359
-1% -$154K
GRMN
1273
Garmin
GRMN
$60.2B
$12.4M ﹤0.01%
195,294
+1,400
+0.7% +$90.6K
ESRT icon
1274
Empire State Realty Trust
ESRT
$831M
$12.4M ﹤0.01%
868,033
-69,306
-7% -$1.08M
NTUS
1275
DELISTED
Natus Medical Inc
NTUS
$12.1M ﹤0.01%
356,641
-10,593
-3% -$344K

Similar funds

T. Rowe Price Associates's Q4 2018 Portfolio in Review

As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

  • T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
  • T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
  • T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
  • T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
  • T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
  • T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
  • T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.

Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.